Explore the power of Next Generation Sequencing (NGS) for biologics development support with our latest whitepaper. Avance Biosciences is at the forefront of NGS testing, offering tailored solutions to support drug development initiatives and GMP manufacturing activities. Delve into real-world case studies, including CRISPR indel amplicon sequencing and insertion site studies, showcasing our expertise in assay development and validation. Learn how we assist leading biopharma companies in characterizing cell line genetic stability and detecting rare mutations in inserted genes using cutting-edge NGS technologies. Download the whitepaper now to discover how Avance Biosciences leverages state-of-the-art NGS to enhance the effectiveness and efficiency of biologic tests.